The Oxford University/AstraZeneca’s coronavirus vaccine has been approved by the United Kingdom regulator.
The country’s health ministry announced that the UK government has accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the Oxford University/AstraZeneca Covid-19 vaccine for use.
The Government in a statement said that it had today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s Covid-19 vaccine for use.
This follows rigorous clinical trials and a thorough analysis of the data by experts at the MHRA, which has concluded that the vaccine has met its strict standards of safety, quality and effectiveness, it said.
UK Prime Minister Boris Johnson in a tweet said, “It is truly fantastic news – and a triumph for British science – that the @UniofOxford /@AstraZeneca vaccine has been approved for use. We will now move to vaccinate as many people as quickly as possible.”
Health Secretary Matt Hancock said, “Brilliant to end 2020 with such a moment of hope: the @UniofOxford / @AstraZeneca #coronavirus vaccine has today been authorised for use by @mhragovuk. The coronavirus vaccine is our way out of the pandemic – now we need to hold our nerve while we get through this together.”
The NHS has a clear vaccine delivery plan and decades of experience in delivering large scale vaccination programmes. It has already vaccinated hundreds of thousands of patients with the Pfizer/BioNTech vaccine and its roll out will continue. Now the NHS will begin putting their extensive preparations into action to roll out the Oxford University/AstraZeneca vaccine, according to the statement.
